Graft versus host disease (GVHD) is a major complication of haematopoietic SCT (HSCT). A number of inflammatory cytokines/chemokines are implicated in GVHD and have been identified in numerous single centre studies as potential biomarkers for acute and/or chronic GVHD. In this study, we analysed candidate inflammatory biomarkers (B-cell activating factor (BAFF), interleukin 33 (IL-33), CXCL10 and CXCL11) in a two-centre study. Biomarkers were evaluated pre-transplant and at serial time points post transplant in acute and chronic GVHD patient sera with time-matched control samples from patients without GVHD. Further validation was performed using the human skin explant assay, clinical GVHD biopsies and mRNA expression analysis. BAFF was significantly increased pre-transplant. BAFF, IL-33, CXCL10 and CXCL11 showed increased levels in acute GVHD patient sera and high protein expression in grades II-III of the in vitro skin explant graft versus host reaction (GVHR) group. BAFF, CXCL10 and CXCL11 also showed increased mRNA expression levels in clinical biopsies compared with the no/low-grade GVHD group. BAFF, CXCL10 and CXCL11 levels were increased in chronic GVHD patient sera. The results identify BAFF and CXCL10 as predictive biomarkers for acute GVHD and BAFF, CXCL10 and CXCL11 as useful diagnostic biomarkers for acute GVHD and chronic GVHD.

3rd Faculty of Medicine Charles University Prague Czech Republic

Haematological Sciences Institute of Cellular Medicine Newcastle University Newcastle upon Tyne UK

Haematological Sciences Institute of Cellular Medicine Newcastle University Newcastle upon Tyne UK Alcyomics Ltd Newcastle upon Tyne UK

Regensburg University Hospital Department of Hematology and Oncology Regensburg Germany

000      

00000naa a2200000 a 4500

001      

bmc16028221

003      

CZ-PrNML

005      

20161021101742.0

007      

ta

008      

161005s2015 enk f 000 0|eng||

009      

AR

024    7_

$a 10.1038/bmt.2015.191 $2 doi

024    7_

$a 10.1038/bmt.2015.191 $2 doi

035    __

$a (PubMed)26367225

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a enk

100    1_

$a Ahmed, S S $u Haematological Sciences, Institute of Cellular Medicine, Newcastle University, Newcastle-upon-Tyne, UK. Alcyomics Ltd, Newcastle-upon-Tyne, UK. $7 gn_A_00002483

245    10

$a Identification and validation of biomarkers associated with acute and chronic graft versus host disease / $c SS. Ahmed, XN. Wang, J. Norden, K. Pearce, E. El-Gezawy, S. Atarod, I. Hromadnikova, M. Collin, E. Holler, AM. Dickinson,

520    9_

$a Graft versus host disease (GVHD) is a major complication of haematopoietic SCT (HSCT). A number of inflammatory cytokines/chemokines are implicated in GVHD and have been identified in numerous single centre studies as potential biomarkers for acute and/or chronic GVHD. In this study, we analysed candidate inflammatory biomarkers (B-cell activating factor (BAFF), interleukin 33 (IL-33), CXCL10 and CXCL11) in a two-centre study. Biomarkers were evaluated pre-transplant and at serial time points post transplant in acute and chronic GVHD patient sera with time-matched control samples from patients without GVHD. Further validation was performed using the human skin explant assay, clinical GVHD biopsies and mRNA expression analysis. BAFF was significantly increased pre-transplant. BAFF, IL-33, CXCL10 and CXCL11 showed increased levels in acute GVHD patient sera and high protein expression in grades II-III of the in vitro skin explant graft versus host reaction (GVHR) group. BAFF, CXCL10 and CXCL11 also showed increased mRNA expression levels in clinical biopsies compared with the no/low-grade GVHD group. BAFF, CXCL10 and CXCL11 levels were increased in chronic GVHD patient sera. The results identify BAFF and CXCL10 as predictive biomarkers for acute GVHD and BAFF, CXCL10 and CXCL11 as useful diagnostic biomarkers for acute GVHD and chronic GVHD.

650    _2

$a akutní nemoc $7 D000208

650    _2

$a alografty $7 D064591

650    _2

$a biologické markery $x krev $7 D015415

650    _2

$a chronická nemoc $7 D002908

650    _2

$a cytokiny $7 D016207

650    _2

$a ženské pohlaví $7 D005260

650    _2

$a nemoc štěpu proti hostiteli $x krev $x diagnóza $x etiologie $7 D006086

650    _2

$a hematologické nádory $x krev $x terapie $7 D019337

650    12

$a transplantace hematopoetických kmenových buněk $7 D018380

650    _2

$a lidé $7 D006801

650    _2

$a mužské pohlaví $7 D008297

655    _2

$a klinické zkoušky $7 D016430

655    _2

$a časopisecké články $7 D016428

655    _2

$a multicentrická studie $7 D016448

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Wang, X N $u Haematological Sciences, Institute of Cellular Medicine, Newcastle University, Newcastle-upon-Tyne, UK. Alcyomics Ltd, Newcastle-upon-Tyne, UK.

700    1_

$a Norden, J $u Haematological Sciences, Institute of Cellular Medicine, Newcastle University, Newcastle-upon-Tyne, UK.

700    1_

$a Pearce, K $u Haematological Sciences, Institute of Cellular Medicine, Newcastle University, Newcastle-upon-Tyne, UK.

700    1_

$a El-Gezawy, E $u Haematological Sciences, Institute of Cellular Medicine, Newcastle University, Newcastle-upon-Tyne, UK.

700    1_

$a Atarod, S $u Haematological Sciences, Institute of Cellular Medicine, Newcastle University, Newcastle-upon-Tyne, UK. $7 gn_A_00009714

700    1_

$a Hromadnikova, I $u Third Faculty of Medicine, Charles University, Prague, Czech Republic.

700    1_

$a Collin, M $u Haematological Sciences, Institute of Cellular Medicine, Newcastle University, Newcastle-upon-Tyne, UK.

700    1_

$a Holler, E $u Regensburg University Hospital, Department of Hematology and Oncology, Regensburg, Germany.

700    1_

$a Dickinson, A M $u Haematological Sciences, Institute of Cellular Medicine, Newcastle University, Newcastle-upon-Tyne, UK. Alcyomics Ltd, Newcastle-upon-Tyne, UK.

773    0_

$w MED00000834 $t Bone marrow transplantation $x 1476-5365 $g Roč. 50, č. 12 (2015), s. 1563-71

856    41

$u https://pubmed.ncbi.nlm.nih.gov/26367225 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20161005 $b ABA008

991    __

$a 20161021102150 $b ABA008

999    __

$a ok $b bmc $g 1166535 $s 952851

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2015 $b 50 $c 12 $d 1563-71 $e 20150914 $i 1476-5365 $m Bone marrow transplantation $n Bone Marrow Transplant $x MED00000834

LZP    __

$a Pubmed-20161005